According to the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), as of today, February 22nd, 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 111 million individuals worldwide. COVID-19 disease, caused by…
Read More
Higher blood pressure from childhood may put Black people at risk for congestive heart failure
Starting with early childhood, otherwise healthy Black people show signs of slightly diminished heart muscle strength and a slightly higher blood pressure than their white counterparts, factors which may put them on a course for early development of congestive heart…
Read More
Firmagon
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Firmagon® Degarelix (as acetate) Powder and Solvent for Injection, depot Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Firmagon. It…
Read More
Abacavir/Lamivudine 600/300 APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ABACAVIR/LAMIVUDINE 600/300 APOTEX TABLET Contains the active ingredients abacavir (as sulfate) and lamivudine Consumer Medicine Information PATIENTS TAKING ABACAVIR AND LAMIVUDINE COMBINATION TABLETS, WHICH CONTAINS ABACAVIR, MAY…
Read More
Zocor (MK)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZOCOR® Simvastatin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ZOCOR.It does not contain all the available information. It does…
Read More
Amlodipine/Valsartan/HCT Novartis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VALSARTAN/AMLODIPINE/HCT NOVARTIS® 5/160/12.5, 5/160/25, 10/160/12.5, 10/160/25, 10/320/25 amlodipine besilate/valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about AMLODIPINE/VALSARTAN/HCT NOVARTIS. It…
Read More
Sudafed Sinus 12 Hour Relief Tablets
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SUDAFED® SINUS 12 HOUR RELIEF TABLETS Pseudoephedrine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SUDAFED® Sinus 12 Hour…
Read More
Alecensa
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALECENSA® ROCALECE10720 alectinib hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Alecensa. It does not contain all the available…
Read More
Aprepitant APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APREPITANT APOTEX aprepitant Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available…
Read More